86 related articles for article (PubMed ID: 6243350)
1. Interobserver variability in the interpretation of myocardial images with Tc-99m-labeled diphosphonate and pyrophosphate.
Cuarón A; Acero AP; Cárdenas M; Huerta D; Rodríguez A; de Garay R
J Nucl Med; 1980 Jan; 21(1):1-9. PubMed ID: 6243350
[No Abstract] [Full Text] [Related]
2. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
Singh A; Usher M
J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
[TBL] [Abstract][Full Text] [Related]
7. [Myocardial scintigraphy with technetium-99m diphosphonate following radiation therapy of the thoracic area (author's transl)].
Neumann G; Standke E; Gottschild D
Radiol Diagn (Berl); 1981; 22(5):690-6. PubMed ID: 7344002
[No Abstract] [Full Text] [Related]
8. Myocardial imaging with Tc-99m pyrophosphate in patients with adriamycin for neoplasia.
Soin JS
J Nucl Med; 1978 May; 19(5):564-5. PubMed ID: 205637
[No Abstract] [Full Text] [Related]
9. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
10. Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis.
Leinonen H; Tötterman KJ; Korppi-Tommola T; Korhola O
Am J Cardiol; 1984 Jan; 53(2):380-1. PubMed ID: 6320621
[No Abstract] [Full Text] [Related]
11. [5 years of pyrophosphate scanning of the heart. A set of results from clinical practice].
Duska F; Novák J; Vizda J; Kafka P; Kubícek J; Veverková O
Cas Lek Cesk; 1982 Aug; 121(33):1043-6. PubMed ID: 6290068
[No Abstract] [Full Text] [Related]
12. [The importance of the current use of pyrophosphate scintigraphy and other noninvasive methods in the detection of cardiac damage in systemic lupus erythematosus].
Duska F; Bradna P; Pospísil M; Kubícek J; Vizda J; Kafka P; Palicka V; Mazurová Y
Cas Lek Cesk; 1986 Sep; 125(38-39):1216-9. PubMed ID: 3022930
[No Abstract] [Full Text] [Related]
13. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
Rudd TG; Allen DR; Hartnett DE
J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
[TBL] [Abstract][Full Text] [Related]
14. [Echography and scintigraphy using technetium 99m pyrophosphate in the diagnosis of cardiac amyloidosis].
Guy JM; Lamaud M; Segura C; Berthaud T; Duranton B; Verneyre H
Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):215-8. PubMed ID: 2544133
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m pyrophosphate myocardial imaging in perimyocarditis.
Ahmad M; Dubiel JP
J Nucl Med; 1981 May; 22(5):452-4. PubMed ID: 6260911
[TBL] [Abstract][Full Text] [Related]
16. A case of myocardial abscess evaluated by radionuclide techniques: case report.
Spies SM; Meyers SN; Barresi V; Grais IM; DeBoer A
J Nucl Med; 1977 Nov; 18(11):1089-90. PubMed ID: 199634
[TBL] [Abstract][Full Text] [Related]
17. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
18. Incidence and consequences of breast artifacts in radionuclide cardiac studies.
Meyer-Pavel C; Clark JK; Pavel DG
Clin Nucl Med; 1982 Feb; 7(2):53-7. PubMed ID: 6277543
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
[TBL] [Abstract][Full Text] [Related]
20. Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams.
Mason JW; Myers RW; Goris ML; Doherty P; Alderman EL; Kriss JP
Clin Cardiol; 1979 Dec; 2(6):446-9. PubMed ID: 232432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
